| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3059 |
| Trial ID | NCT05400109 |
| Disease | Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | UF-KURE19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas |
| Year | 2022 |
| Country | United States |
| Company sponsor | James Michael Martin |
| Other ID(s) | CASE2422 |
| Vector information | |||
|
|||
| Cohort1: Participants ≥50 kg | |||||||||||
|
|||||||||||
| Cohort2: Participants <50 kg | |||||||||||
|
|||||||||||